Dr. Kamada’s lab investigates how gut microbiota and host immunity interact in gastrointestinal health and disease. Their focus is on the mechanism by which certain pathogenic members of commensal bacteria promote chronic intestinal inflammation that leads to Inflammatory Bowel Disease.
Dr. Ekici is using the newest technology for high-throughput profiling and data analysis in a broad spectrum of human genetics research.
The Fairn lab studies a variety of aspects related to vesicular and non-vesicular transport of lipids, lipid metabolism, membrane dynamics and the cell biology of immune cells.
By coordinating collaborative multi-disciplinary research efforts and public-private consortium, Dr. Colombel implements major clinical trials that have the potential to significantly improve treatments for patients across the spectrum of IBD.
Dr. Davis’s lab focuses on the mechanical and electrophysiological properties of lymphatic smooth muscle and endothelium and how dysfunction of those cell types contributes to lymphedema.
Dr. Denson’s multi-center research program focuses on discovering underlying mechanisms and better therapeutic approaches in chronic inflammation, growth and mucosal healing related to adult and pediatric patients with IBD.
The Fitzgerald lab investigates the molecular mechanism controlling the innate immune response during infection and inflammation. They focus on therapeutic targeting of Inflammasomes and nucleic acid sensing pathways to treat inflammatory diseases.
Dr. Gerwert works in the field of protein science, aiming to detect neurodegenerative diseases at an early stage to prevent progression to symptomatic conditions.
Using genetic approaches, the Guo lab seeks to understand and reprogram the molecular “language” of host-microbe interactions in health and disease for potential therapeutic applications.
The Hinterleitner lab is interested in the fascinating yet complex events happening in our intestines every day. They are trying to understand the crosstalk between intestinal microbes, diets and the host mucosal immune system.
The Kenneth Rainin Foundation enhances quality of life by championing the arts, promoting early childhood literacy, and supporting research to cure chronic disease.
©2023-2025 Kenneth Rainin Foundation. All rights reserved.
Privacy Policy
Site by Mission Minded.
Connect with us